Mesti, Tanja, et al. “NMR Metabolic Fingerprint of Bevacizumab in Mutant IDH1 Glioma Cells”. Radiology and Oncology, vol. 52, no. 4, Dec. 2018, https://www.radioloncol.com/index.php/ro/article/view/2963.